More Diagnostics, Inc. Signs an Agreement with Emery Pharma

LOS OSOS, Calif., April 11, 2018 /PRNewswire/ -- More Diagnostics, Inc., an employee owned developer and manufacturer of clinical diagnostic controls and Emery Pharma, a full-service contract research & development organization, specializing in microbiology, cell biology medicinal chemistry and bioanalytical services, announced the signing of a four-year agreement with Emery Pharma to provide Liquid Chromatography Mass Spectrometry (LC-MS) services to More Diagnostics. The agreement covers the analysis of the full range of analytes available in the controls for immunoassays used for testing immunosuppressant drugs, such as Everolimus, Tacrolimus, Cyclosporine and Sirolimus (Rapamycin).

"We are very pleased to team with Emery Pharma as our partner in maintaining the highest level of quality and integrity of our products and collaborate with us the on-going development of new products," commented Endre Vargha, CEO of More Diagnostics.

About More Diagnostics

Founded in 1993, More Diagnostics is the leader in providing immunosuppressant assay controls to diagnostic equipment OEMs, hospitals and laboratories with worldwide distribution channels. Keeping with More's commitment for delivering reliable quality controls, the company has developed a stable liquid whole-blood Cyclosporine control that became the standard for the industry. Located on the Central Coast of California, the Company is fully certified; FDA and CMDCAS licensed, ISO 14385 certified including the CE Mark.

About Emery Pharma

Emery Pharma is an FDA registered, DEA licensed and cGMP/GLP compliant contract research & development organization focused on supporting mid-size biotech, pharma, synthetic fuel, agro chemistry, and novel battery technology. Located in Alameda, CA, Emery Pharma's experienced chemists and biologists, utilize modern, qualified equipment for a large variety of studies, including NMR, LCMS, Prep-HPLC, ICPMS, stability, dissolution, litigation support, expert witness and consulting services. The team also has significant experience and capabilities in medical chemistry, biological screening, and formulation development.  

Contact More Diagnostics at +1-800-758-0978 or send a message via its website https://www.morediagnostics.com/contact-us/

Contact Emery Pharma at +1-888-983-6379 or send a message through its website https://emerypharma.com/contact/

For More Diagnostics Media Relations
Contact Jasmine Moore at +1-805-528-6005
[email protected]
Connect with us on LinkedIn

SOURCE More Diagnostics, Inc.